Medical/Pharmaceuticals

NEOM Investment Fund partners with Paradromics to drive innovation in neurotechnology healthcare

Strategic partnership with Paradromics will accelerate advancements in brain-computer interfaces and establish a Center of Excellence in NEOM. AUSTIN, Texas, Feb. 13, 2025 /PRNewswire/ -- Paradromics, Inc., a global leader in high-data rate brain-computer interface (BCI) technology, announced a ...

2025-02-13 00:38 2364

TriNetX and Fujitsu Launch Joint Venture to Increase Japanese Patients' Access to Life-Changing Medicines

Partnership taps real-world data to accelerate clinical trials, research, and drug development inJapan.   CAMBRIDGE, Mass., Feb. 12, 2025 /PRNewswire/ -- TriNetX, a global leader in real-world data (RWD) and real-world evidence (RWE) solutions, has partnered with Fujitsu, a global ICT company an...

2025-02-12 21:02 3513

AIM Vaccine Leverages AI to Advance mRNA Vaccine Development mRNA Shingles Vaccine Submits Clinical Trial Application

HONG KONG, Feb. 12, 2025 /PRNewswire/ -- AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement onFebruary 11, 2025, announced that its independently developed mRNA shingles vaccine has been submitted for clinical trials to the Center for Drug Evaluation (CDE) ...

2025-02-12 13:15 2929

Lion TCR's Liocyx-M004 Receives FDA Clearance to Launch Global Multicenter Phase 2 Clinical Trial in HBV-Related Hepatocellular Carcinoma

SINGAPORE, Feb. 12, 2025 /PRNewswire/ -- On 12 Feb 2025, Lion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has received clearance from the U.S. Food and Drug Administration (FDA) to initiate an international multicenter Phase 2 clinical trial. This ...

2025-02-12 09:00 4399

Alexandra Hospital develops world's novel A.I. algorithm (with international patent) that enhances accuracy and efficiency of robotic total knee replacement

Newspoints: * An A.I. algorithm for robotic total knee replacement (rTKR) has secured an international Patent Cooperation Treaty (PCT) patent[1], that protects this algorithm for robotic total knee replacement for its uniqueness, exclusivity, novelty and proprietary rights. Filed sinceAugust 2...

2025-02-12 09:00 4338

Forescout Recognized by Frost & Sullivan with the 2025 Global Product Leadership Award for Enabling Single Platform Approach to Medical Device Security

Forescout's Platform offers comprehensive, real-time visibility across organizational network architecture, and boosts the operational efficiency and overall productivity of under resourced healthcare security teams. SAN ANTONIO, Feb. 11, 2025 /PRNewswire/ -- Recently Frost & Sullivan assessed t...

2025-02-11 22:00 2536

Cubresa and Siemens Healthineers Sign Global Master Interface Agreement for the Cubresa BrainPET™ Scanner

WINNIPEG, MB, Feb. 11, 2025 /PRNewswire/ -- Cubresa is pleased to announce that it has signed a global Master Interface Agreement with Siemens Healthineers. The agreement is a broad contract designed to support development efforts and compatibility testing of the Cubresa BrainPET™ scanner in Siem...

2025-02-11 21:00 2257

ZIWIG ENDOTEST®: FAST-TRACK REIMBURSEMENT FOR 25 000 PATIENTS FOR FIRST SALIVA TEST TO DIAGNOSE ENDOMETRIOSIS IN 80 MEDICAL CENTERS IN FRANCE

LYON, France, Feb. 11, 2025 /PRNewswire/ -- Ziwig, a French biotech company committed to advancing women's health, announces the fast-track reimbursement of Ziwig Endotest® - the first saliva diagnostic test for endometriosis- for 25 000 patients across 80 medical centers inFrance thanks to the I...

2025-02-11 20:07 3789

Infinitus Secures Approval for National-Level Joint Laboratory Project, Ushering in a New Chapter of China-Europe Scientific Research Collaboration

GUANGZHOU, China, Feb. 10, 2025 /PRNewswire/ – In a significant announcement at the recent Infinitus Global Annual Meeting, Infinitus (China) Company Ltd. secured approval for its Sino-British Joint Laboratory on Health and Aging project. This initiative is part of the intergovernmental internati...

2025-02-11 15:27 3096

Bio X Cell Expands Global Reach with New Distribution Center in Beijing, China

LEBANON, N.H., Feb. 11, 2025 /PRNewswire/ -- Bio X Cell, the world's leading provider of functional antibodies for translational research, is strengthening its global distribution network with the opening of a new distribution center in Beijing, China, in March 2025. This expansion marks the lates...

2025-02-11 15:00 2176

Bangkok Dusit Medical Services and CNN joined forces to address global health challenges and explore next-gen solutions

HONG KONG, Feb. 10, 2025 /PRNewswire/ -- Bangkok Dusit Medical Services Public Company Limited (BDMS), the largest private healthcare network inThailand, has continued its long-term partnership with CNN International Commercial (CNNIC) through the sponsorship ofVital Signs hosted by Dr. Sanjay Gu...

2025-02-10 17:16 3216

2025 Singclean Global Aesthetic Master Symposium Debuted in France

PARIS, Feb. 10, 2025 /PRNewswire/ -- 2025 IMCAS World Congress, the world's largest scientific aesthetics congress, was grandly held inParis from January 30 to February 1, celebrating its 26th anniversary.   SINGCLEAN highlight video in IMCAS 2025 Singclean Medical showcased its flagship HA fil...

2025-02-10 11:18 1339

Babies Bliss Singapore: Holistic Support for Couples Trying to Conceive During the Festive Season

Helping Couples Navigate Fertility Challenges with Care and Compassion SINGAPORE, Feb. 7, 2025 /PRNewswire/ -- As the festive season approaches, many couples facing fertility challenges experience added emotional stress, making it a vulnerable time for those trying to conceive. Babies Bliss Sing...

2025-02-07 15:09 3336

Bowtie Collaborate with Gleneagles Hospital Hong Kong and Pfizer Hong Kong to Promote Health Education

Aims to boost health awareness for migraine, disease impacting over 900,000 Hongkongers[1] HONG KONG, Feb. 7, 2025 /PRNewswire/ -- Bowtie, Hong Kong's first virtual insurer[2], collaborates with Gleneagles Hospital Hong Kong and Pfizer Hong Kong to promote health education. With the aim of encou...

2025-02-07 14:41 4006

Nuance Pharma Announces Approval of Ohtuvayre™ (ensifentrine) in Macau SAR, China

Ohtuvayre™is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients First inhaled COPD treatment providing bronchodilation and non-steroidal anti-inflammatory effects SHANGHAI, Feb. 7, 2025 /PRNewswire/ -- Today, Nuance Pharma ("Nuance") announ...

2025-02-07 09:00 6539

Corti's First AId Report: Burnout levels challenge healthcare professionals' ability to care for patients in Europe and the U.S.

Artificial Intelligence could be a lifeline but unsuccessful trials, limited opportunities, and lack of experience is holding healthcare professionals back * Europe lagging behind the U.S. in terms of acceptance and adoption of AI and differences exist within the European markets * U.S. healt...

2025-02-06 22:31 3030

Stroke Detection Innovator Wellumio Enrolls First Patient in Australian Clinical Trial for 'Axana' 0.1T portable magnetic resonance imaging device (Portable MRI study)

"Revolutionary portable device leverages advanced magnetic resonance technology to rapidly detect acute stroke biomarkers, enabling frontline care teams to make faster, life-saving decisions within the critical 'golden hour." A Melbourne hospital images the first patient in Australia using the We...

2025-02-06 21:15 3061

Henlius and Dr. Reddy's Ink Licensing Deal for HLX15 (investigational daratumumab biosimilar) Expansion in Europe and the U.S.

SHANGHAI, Feb. 6, 2025 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) today announced it has entered into a license agreement with Dr. Reddy's Laboratories SA, wholly-owned subsidiary of Dr. Reddy's Laboratories Ltd., (BSE: 500124 | NSE: DRREDDY | NYSE: RDY | NSEIFSC: DRREDDY, along wit...

2025-02-06 19:40 3833

Anti-HER2 Bispecific ADC JSKN003 Received Approval to Initiate a Phase III Clinical Study for the Treatment of HER2-positive Breast Cancer

SUZHOU, China, Feb. 6, 2025 /PRNewswire/ -- Alphamab Oncology (Stock Code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. ("CSPC") (Stock Code: 1093.HK) jointly announced that anti-HER2 biparatopic antibody-drug conjugate (ADC) JSKN003 has received approval from the Center for Drug Evaluation (...

2025-02-06 14:05 3718

Medidata Advances New Frontiers for Life Sciences Through Patient-Centric Experiences, AI-Powered Innovations, and New Patient Engaging Alliances

In the era of the generative economy, Medidata is transforming how industries are empowering patients with new cure and care experiences and lifelong engagement SINGAPORE, Feb. 6, 2025 /PRNewswire/ -- Medidata , a Dassault Systèmes brand, reaffirms its vision and c...

2025-02-06 13:00 4541
1 ... 71727374757677 ... 395